Literature DB >> 2846691

Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.

D C Diamond1, B P Sleckman, T Gregory, L A Lasky, J L Greenstein, S J Burakoff.   

Abstract

The CD4 molecule is functionally involved in the class II MHC-restricted T cell response to Ag. CD4 is also the receptor for HIV-1, the major etiologic agent of AIDS. We have assessed whether the interaction of the HIV-1 envelope protein with the CD4 molecule might interfere with the normal function of CD4, thereby contributing to the immunosuppression observed after HIV infection. Using a murine T cell hybridoma which expresses the human CD4 protein and exhibits a CD4-dependent response to Ag, we demonstrate that the HIV envelope protein gp120 can specifically inhibit this response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Authors:  C Terai; R S Kornbluth; C D Pauza; D D Richman; D A Carson
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells.

Authors:  F Manca; L Walker; A Newell; F Celada; J A Habeshaw; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15.

Authors:  Renu Garg; Ignacio J Juncadella; Nandhini Ramamoorthi; Shobana K Ananthanarayanan; Venetta Thomas; Mercedes Rincón; Joanna K Krueger; Erol Fikrig; Christopher M Yengo; Juan Anguita
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

4.  An idiotypic network model of AIDS immunopathogenesis.

Authors:  G W Hoffmann; T A Kion; M D Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Authors:  J P Moore; J A McKeating; Y X Huang; A Ashkenazi; D D Ho
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.

Authors:  Nichole Cerutti; Mark Killick; Vinesh Jugnarain; Maria Papathanasopoulos; Alexio Capovilla
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 7.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

8.  HIV-induced changes in T cell signaling pathways.

Authors:  Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.

Authors:  P Bérubé; B Barbeau; R Cantin; R P Sékaly; M Tremblay
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.

Authors:  A Faith; R E O'Hehir; M Malkovsky; J R Lamb
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.